ResApp Health Ltd (RAP) - Financial and Strategic SWOT Analysis Review

ResApp Health Ltd (RAP) - Financial and Strategic SWOT Analysis Review


  • Products Id :- GDPH82556FSA
  • |
  • Pages: 39
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

ResApp Health Ltd (RAP)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities-A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

ResApp Health Ltd (ResApp) formerly, Narhex Life Sciences Limited is a digital health company that develops smartphone applications for the diagnosis and management of respiratory disease. It's digital healthcare solutions assist doctors and patients to diagnose and manage respiratory diseases. The company develops diagnostic tools that require a smartphone. ResApp has license from The University of Queensland for technology that uses sound to diagnose respiratory diseases including upper respiratory tract infections, pneumonia, bronchitis, asthma and chronic obstructive pulmonary disease (COPD). Markets for ResApp's technology include emergency department and regular clinic use by healthcare providers, at-home use by consumers and tele-health use through partnerships with tele-health service providers. ResApp is headquartered in Brisbane, Queensland, Australia.

ResApp Health Ltd Key Recent Developments

Nov 05,2018: ResApp receives notice of allowance for core patent in Japan

Aug 16,2018: ResApp Partners with Lockheed Martin for U.S. Government Agency Research Program

Aug 15,2018: ResApp receives notice of acceptance for core patent in Australia

Jun 28,2018: ResApp Provides Update on Australian Clinical Study

Dec 18,2017: ResApp Announces Further Positive Results from Australian Adult Clinical Studies

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Section 1-About the Company 5

ResApp Health Ltd-Key Facts 5

ResApp Health Ltd-Key Employees 6

ResApp Health Ltd-Key Employee Biographies 7

ResApp Health Ltd-Major Products and Services 8

ResApp Health Ltd-History 9

ResApp Health Ltd-Locations And Subsidiaries 11

Head Office 11

Other Locations & Subsidiaries 11

Section 2-Company Analysis 12

Company Overview 12

ResApp Health Ltd-Business Description 13

ResApp Health Ltd-SWOT Analysis 14

SWOT Analysis-Overview 14

ResApp Health Ltd-Strengths 14

ResApp Health Ltd-Weaknesses 15

ResApp Health Ltd-Opportunities 16

ResApp Health Ltd-Threats 17

ResApp Health Ltd-Key Competitors 18

Section 3-Company Financial Ratios 19

Financial Ratios-Capital Market Ratios 19

Financial Ratios-Annual Ratios 20

Performance Chart 22

Financial Performance 22

Financial Ratios-Interim Ratios 23

Financial Ratios-Ratio Charts 24

Section 4-Company's Lifesciences Financial Deals and Alliances 25

ResApp Health Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 25

ResApp Health Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 26

ResApp Health Ltd, Recent Deals Summary 27

Section 5-Company's Recent Developments 28

Nov 05, 2018: ResApp receives notice of allowance for core patent in Japan 28

Aug 16, 2018: ResApp Partners with Lockheed Martin for U.S. Government Agency Research Program 29

Aug 15, 2018: ResApp receives notice of acceptance for core patent in Australia 30

Jun 28, 2018: ResApp Provides Update on Australian Clinical Study 31

Dec 18, 2017: ResApp Announces Further Positive Results from Australian Adult Clinical Studies 32

Aug 23, 2017: Dr Philip Currie Joins ResApp's Scientific Advisory Board 33

Aug 21, 2017: ResApp Receives R&D Tax Incentive Cash Refund for FY16 34

Section 6-Appendix 35

Methodology 35

Ratio Definitions 35

About GlobalData 39

Contact Us 39

Disclaimer 39

List of Figures

ResApp Health Ltd, Performance Chart (2014-2018) 22

ResApp Health Ltd, Ratio Charts 24

ResApp Health Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 25

ResApp Health Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 26

List of Tables

ResApp Health Ltd, Key Facts 5

ResApp Health Ltd, Key Employees 6

ResApp Health Ltd, Key Employee Biographies 7

ResApp Health Ltd, Major Products and Services 8

ResApp Health Ltd, History 9

ResApp Health Ltd, Subsidiaries 11

ResApp Health Ltd, Key Competitors 18

ResApp Health Ltd, Ratios based on current share price 19

ResApp Health Ltd, Annual Ratios 20

ResApp Health Ltd, Annual Ratios (Cont...1) 21

ResApp Health Ltd, Interim Ratios 23

ResApp Health Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 25

ResApp Health Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 26

ResApp Health Ltd, Recent Deals Summary 27

Currency Codes 35

Capital Market Ratios 35

Equity Ratios 36

Profitability Ratios 36

Cost Ratios 37

Liquidity Ratios 37

Leverage Ratios 38

Efficiency Ratios 38

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

Welch Allyn Inc

ResMed Inc.

Genetic Signatures Ltd

GE Healthcare LLC

Alere Inc

ResApp Health Ltd, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts

select a license
Single User License
USD 125 INR 8750
Site License
USD 250 INR 17500
Corporate User License
USD 375 INR 26250

NEWSLETTER BY CATEGORY




Testimonials

The report was very informative and gives me an interesting view on the Indian market....

We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help...

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com